Ambalal Sarabhai Enterprises Limited has scheduled its 48th Annual General Meeting (AGM) for July 30, 2026, to be conducted through video conferencing and other audio-visual means. The meeting will address business outlined in the notice dated May 21, 2026. The company has established July 28, 2026, as the record date to determine shareholder eligibility for the AGM and voting rights.

The Register of Members and Share Transfer Books will remain closed from July 28, 2026, to July 30, 2026. In compliance with Section 108 of the Companies Act, 2013, and relevant SEBI regulations, the company is facilitating remote e-voting. Shareholders can cast their votes remotely starting at 9:00 AM IST on July 27, 2026, until 5:00 PM IST on July 29, 2026. The cut-off date for determining entitlements for remote e-voting is July 23, 2026.

The Annual Report for FY 2025-26 has been dispatched electronically to members with registered email addresses as of July 7, 2026. Shareholders without registered email details have been sent a letter providing the web link to access the report on the company's website. The documents are also available on the BSE website and CDSL's e-voting portal.

Members holding shares in physical form must submit requests to the Registrar and Transfer Agents or the company to register email addresses and bank details. Those holding shares in demat form should update their details through their Depository Participant. The company has designated Mr. Rakesh Dalvi, Senior Manager at CDSL, as the official to address grievances related to remote e-voting.

Ambalal Sarabhai Enterprises Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone and consolidated financial results during its meeting held on May 21, 2026.

Consolidated Financial Performance

For the financial year ended March 31, 2026, the company reported a consolidated net profit of ₹1,780.32 lakh, a sharp rise from ₹493.17 lakh in the previous year. Revenue from operations grew to ₹20,227.17 lakh from ₹19,618.53 lakh in FY25. Total income for the year increased to ₹21,744.34 lakh. The profit before tax for the year stood at ₹1,850.64 lakh.

In the quarter ended March 31, 2026, the consolidated net profit was ₹650.11 lakh, compared to a loss of ₹26.70 lakh in the same period last year. Revenue from operations for the quarter was ₹6,548.73 lakh, while total income stood at ₹6,809.91 lakh.

Standalone Results

On a standalone basis, the company reported a net profit of ₹1,099.09 lakh for the year ended March 31, 2026, compared to ₹824.18 lakh in the previous year. Revenue from operations for the year was ₹394.37 lakh. For the quarter ended March 31, 2026, the standalone net profit was ₹265.14 lakh.

Board Decisions and Appointments

The Board approved the re-appointment of M/s. Gautam Joshi & Co. as the internal auditor for FY 2026-27. Additionally, the Board recommended the re-appointment of Mr. Kartikeya V. Sarabhai as Executive Chairman for three years effective April 1, 2027, and Mr. Mohal K. Sarabhai as Managing Director for three years effective September 21, 2026. Ms. Chaula M. Shastri was also recommended for re-appointment as Whole-time Director for three years effective April 1, 2027.

The Board approved the continuation of Mr. Govindprasad Namdeo as a Non-Executive Independent Director upon attaining the age of 75 years. The 48th Annual General Meeting is scheduled to be held on July 30, 2026, via video conferencing. The Board also recommended granting inter-corporate loans to Asence Pharma Private Limited, Synbiotics Limited, and Systronics India Limited.